title: Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon.
authors.affiliation: Uludag University Faculty of Medicine Division of Pediatric Immunology and Rheumatology, Uludag University School of Medicine, Bursa, Turkey drsukrucekic@gmail.com.
authors.forename: S
authors.initials: S
authors.lastname: Cekic
authors.affiliation: Uludag University Faculty of Medicine Division of Pediatric Immunology and Rheumatology, Uludag University School of Medicine, Bursa, Turkey.
authors.forename: S S
authors.initials: SS
authors.lastname: Kilic
mesh_terms: D000293:Adolescent; D017668:Age of Onset; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis; D002648:Child; D005260:Female; D005528:Foot / Q000098:blood supply*; D016523:Foot Ulcer / Q000209:etiology; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D007511:Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011928:Raynaud Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012039:Regional Blood Flow; D016896:Treatment Outcome; D014661:Vasoconstriction / Q000187:drug effects*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects
chemical_list: D014665:Vasodilator Agents; D016285:Iloprost